MAPK3 and breast carcinoma: Interestingly, murine mammary carcinoma, lymphoma, and fibrosarcoma with a mutated and activated RAS/RAF/MEK/ERK1/2 axis promote the expansion of activated CD8+TILs, producing IFN-γ that initially induces tumor cell killing.